Allergan strengthens women’s health focus with $26m buy

13-12-2017

Allergan has boosted its focus on women’s health with the acquisition of Repros Therapeutics, a development stage biopharmaceutical company.


Allergan, mergers & acquisitions, M&A, Repros Therapeutics, small molecule drugs, women’s health

LSIPR